Vicore Pharma Holding AB SEC filings VCRE
Vicore Pharma Holding AB has 13 filings in SEC EDGAR's recent list, going back to Apr 17, 2026. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 5, 2026 | Nov 30, 2026 |
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 31, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 21, 2026 | Aug 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 6, 2026 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VCRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Sweden
- Headquarters
- Stockholm
- SEC CIK
- 2124403
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.